Skip to main Content
Site Search

Advanced Search

  • Mondo Visione
  • Mondo Visione - Worldwide Exchange Intelligence
Member Login

Member Login

Forgotten your password?

New Graduates From Euronext Dublin's Strategic Financing Programme #IPOready - Euronext Dublin Hosted A Graduation Ceremony For #IPOREADY Programme Participants

Date 22/01/2019

Twelve high-potential companies have graduated from #IPOready, Euronext Dublin’s leadership programme for executives looking to enhance their skillsets for scaling their companies and raising strategic finance. The programme assists executives to get their company funding ready, to understand the sources of funding available and to craft their investment pitch. Chief Executive Officers (CEOs) and Chief Financial Officers (CFOs) from a range of sectors including agri-tech, bio medical technology, construction, engineering, technology and financial services across the island of Ireland took part in the 15-month programme.

#IPOready is supported by Enterprise Ireland and the Ireland Strategic Investment Fund and provides:

  • expert training and insights from over 100 top advisors, experienced investors, entrepreneurs, and leading Irish corporates on large scale corporate funding, business development and investor relations;
  • networking opportunities with other ambitious companies, experienced leaders and industry experts;
  • access to over 25 domestic and international investor organisations to pitch their company’s investment story and receive feedback; and
  • support in achieving plans for scaling and strategic finance through one-on-one coaching.

Julie Sinnamon, CEO of Enterprise Ireland said, “Enterprise Ireland’s ambition is to grow the number of Irish businesses of scale, as a back-bone of the economy. Access to appropriate and adequate sources of strategic finance to fund each stage of growth, is essential. We are pleased to collaborate with Euronext on the ‘IPOready programme’ to help demystify the IPO journey and equip business owners with the knowledge and skills to raise funds on the Irish and/or international stock exchanges. We look forward to working with Euronext on future IPOready programmes and to more Irish IPO success stories.”

Padraic Clarke, CFO of Atlantic Therapeutics said, “I would recommend the IPOready programme to any growing Irish company looking to access significant finance as a critical strategic enabler of their growth. Even if an IPO is not the ultimate source of that finance, the learnings that I took away from the programme are relavent to any fundraising situation, and were of benefit to Atlantic Therapeutics in our recent equity fundraising. IPOready has provided us a fantastic opportunity to meet other companies in a similar position and to learn from their experiences as well as providing contacts with potential advisors and investors for the future.”

Laurence Flavin, CFO of Finance Ireland, said “We were delighted to be part of the IPOready programme.  It was a natural step in the progression of a high growth business like Finance Ireland, as Ireland’s largest non-bank lender.  The programme put us in a positive environment with companies of a similar DNA and gave us access to the expertise and resources needed in considering the suitability of an IPO for our business in the future.  We would strongly recommend the programme to other companies with a track record and growth ambitions.

Orla O’Gorman, Head of Equity Listing, Euronext Dublin said, “Congratulations to the fantastic, ambitious, companies graduating from our #IPOready programme. The strength and caliber of the teams as they developed over the programme never ceased to impress and inspire. We are so excited to watch what these companies will do in the coming months and years ahead and wish them every success on their journey.

Ambitious growing companies with turnover in excess of €5m and are interested in participating in the #IPOready programme, commencing September 2019, should contact Orla O’Gorman, Head of Equity Listing at OOGorman@euronext.com to register their interest.